These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Recessive POLG mutations presenting with sensory and ataxic neuropathy in compound heterozygote patients with progressive external ophthalmoplegia. Van Goethem G; Martin JJ; Dermaut B; Löfgren A; Wibail A; Ververken D; Tack P; Dehaene I; Van Zandijcke M; Moonen M; Ceuterick C; De Jonghe P; Van Broeckhoven C Neuromuscul Disord; 2003 Feb; 13(2):133-42. PubMed ID: 12565911 [TBL] [Abstract][Full Text] [Related]
43. Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration. Jimenez-Ferrer I; Jewett M; Tontanahal A; Romero-Ramos M; Swanberg M Neurobiol Dis; 2017 Oct; 106():279-290. PubMed ID: 28736195 [TBL] [Abstract][Full Text] [Related]
44. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease. Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353 [TBL] [Abstract][Full Text] [Related]
45. Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons. López de Maturana R; Lang V; Zubiarrain A; Sousa A; Vázquez N; Gorostidi A; Águila J; López de Munain A; Rodríguez M; Sánchez-Pernaute R J Neuroinflammation; 2016 Nov; 13(1):295. PubMed ID: 27863501 [TBL] [Abstract][Full Text] [Related]
48. Generation of Naivetropic Induced Pluripotent Stem Cells from Parkinson's Disease Patients for High-Efficiency Genetic Manipulation and Disease Modeling. Hu Z; Pu J; Jiang H; Zhong P; Qiu J; Li F; Wang X; Zhang B; Yan Z; Feng J Stem Cells Dev; 2015 Nov; 24(21):2591-604. PubMed ID: 26218671 [TBL] [Abstract][Full Text] [Related]
49. Revisiting mitochondrial ocular myopathies: a study from the Italian Network. Orsucci D; Angelini C; Bertini E; Carelli V; Comi GP; Federico A; Minetti C; Moggio M; Mongini T; Santorelli FM; Servidei S; Tonin P; Ardissone A; Bello L; Bruno C; Ienco EC; Diodato D; Filosto M; Lamperti C; Moroni I; Musumeci O; Pegoraro E; Primiano G; Ronchi D; Rubegni A; Salvatore S; Sciacco M; Valentino ML; Vercelli L; Toscano A; Zeviani M; Siciliano G; Mancuso M J Neurol; 2017 Aug; 264(8):1777-1784. PubMed ID: 28695364 [TBL] [Abstract][Full Text] [Related]
50. Sequence analysis of familial PEO shows additional mutations associated with the 752C-->T and 3527C-->T changes in the POLG1 gene. Lamantea E; Zeviani M Ann Neurol; 2004 Sep; 56(3):454-5. PubMed ID: 15349879 [No Abstract] [Full Text] [Related]
51. Isolation of LMX1a Ventral Midbrain Progenitors Improves the Safety and Predictability of Human Pluripotent Stem Cell-Derived Neural Transplants in Parkinsonian Disease. de Luzy IR; Niclis JC; Gantner CW; Kauhausen JA; Hunt CPJ; Ermine C; Pouton CW; Thompson LH; Parish CL J Neurosci; 2019 Nov; 39(48):9521-9531. PubMed ID: 31641054 [TBL] [Abstract][Full Text] [Related]
52. Comparison of the time courses of selective gene expression and dopaminergic depletion induced by MPP+ in MN9D cells. Wang J; Duhart HM; Xu Z; Patterson TA; Newport GD; Ali SF Neurochem Int; 2008 May; 52(6):1037-43. PubMed ID: 18069091 [TBL] [Abstract][Full Text] [Related]
53. Derivation of dopaminergic neurons from pluripotent stem cells. Studer L Prog Brain Res; 2012; 200():243-63. PubMed ID: 23195422 [TBL] [Abstract][Full Text] [Related]
54. A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism. Aflaki E; Borger DK; Moaven N; Stubblefield BK; Rogers SA; Patnaik S; Schoenen FJ; Westbroek W; Zheng W; Sullivan P; Fujiwara H; Sidhu R; Khaliq ZM; Lopez GJ; Goldstein DS; Ory DS; Marugan J; Sidransky E J Neurosci; 2016 Jul; 36(28):7441-52. PubMed ID: 27413154 [TBL] [Abstract][Full Text] [Related]
55. Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons. Caudal D; Alvarsson A; Björklund A; Svenningsson P Exp Neurol; 2015 Nov; 273():243-52. PubMed ID: 26363495 [TBL] [Abstract][Full Text] [Related]
56. POLG1-related and other "mitochondrial Parkinsonisms": an overview. Orsucci D; Caldarazzo Ienco E; Mancuso M; Siciliano G J Mol Neurosci; 2011 May; 44(1):17-24. PubMed ID: 21221844 [TBL] [Abstract][Full Text] [Related]
57. A novel Kurt B; Naini AB; Copeland WC; Lu J; Dimauro S; Hirano M J Exp Integr Med; 2012; 2(2):. PubMed ID: 24265579 [TBL] [Abstract][Full Text] [Related]
58. Molecular Features Underlying Neurodegeneration Identified through In Vitro Modeling of Genetically Diverse Parkinson's Disease Patients. Lin L; Göke J; Cukuroglu E; Dranias MR; VanDongen AM; Stanton LW Cell Rep; 2016 Jun; 15(11):2411-26. PubMed ID: 27264186 [TBL] [Abstract][Full Text] [Related]
59. Leukoencephalopathy with a case of heterozygous POLG mutation mimicking mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Yasuda K; Murase N; Yoshinaga K; Ohtani R; Goto YI; Takahashi R; Nakamura M J Clin Neurosci; 2019 Mar; 61():302-304. PubMed ID: 30385167 [TBL] [Abstract][Full Text] [Related]
60. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease. Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]